Voloridge Investment Management, LLC Karyopharm Therapeutics Inc. Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.15 - $8.37 $1.19 Million - $2.41 Million	-287,670 Reduced 42.5%	389,164 $1.76 Million
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $2.83 Million - $6.89 Million	479,443 Added 242.89%	676,834 $4.99 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $1.03 Million - $1.7 Million	197,391 New	197,391 $1.27 Million
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $841,230 - $1.62 Million	-58,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $539,955 - $1.15 Million	58,500 New	58,500 $1.12 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.